RE:RE:RE:RE:RE:Phase 3: New ValuationToinv261,
I was under the impression If a buyout occured that RVX could not sell for less than $13.74 but sell for far more if the market allowed. Not sure if there was a time limit on that deal as well.
Now that we are going into a phase 3 program our market value should be IMO much much higher based on possible future revenue streams to Big pharma. Phase 3 prograsm without post hoc analysis usually have a 70% success rate in phase 3 and we are 2 to 3years away from there, which would make this a blockbuster drug with revenues per of at least $1 to $3 Billion til 2035 IMO. What is RVX worth to BP at that point. based on those multiples of revenue for 15 years. I say alot more than $13.74 which would be about $1 billion to RVX
Just my opinion
GLTA,